MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
1. Triple Helix _ Sectors
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Europe: Regions
*Western Europe
United Kingdom_UK (England, Scotland, Wales, Northern Ireland)
Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
Datar Cancer Genetics
Attachments
Datar Cancer Genetics
Parents
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Breast
Architects: Diagnostics_Liquid Biopsy
FDA _ Breakthrough Devices Program
Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
Children
2021: Latest breakthrough device designations go to brain-computer interface, exo-suit
Datar received its breakthrough status for a breast cancer blood test, called TriNetra.
The test looks for circulating tumor cells to detect early-stage breast cancer in women aged 40 years and up
TriNetra™ uses a proprietary technology developed by the Company to detect Circulating Tumor Cells (CTCs) specific to Breast Cancer. Studies have shown that TriNetra™ can detect even Stage 0 (DCIS) and Stage 1 cancers with high accuracy.